STRAUMANN HOLDING AG-REG (QS51.DE) Stock Fundamental Analysis
FRA:QS51 - Deutsche Boerse Ag - CH1175448666 - Common Stock - Currency: EUR
Taking everything into account, QS51 scores 7 out of 10 in our fundamental rating. QS51 was compared to 57 industry peers in the Health Care Equipment & Supplies industry. QS51 has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QS51 is valied quite expensively at the moment, while it does show a decent growth rate. This makes QS51 very considerable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year QS51 was profitable.
In the past year QS51 had a positive cash flow from operations.
Each year in the past 5 years QS51 has been profitable.
Each year in the past 5 years QS51 had a positive operating cash flow.
1.2 Ratios
QS51 has a Return On Assets of 10.73%. This is amongst the best in the industry. QS51 outperforms 87.72% of its industry peers.
Looking at the Return On Equity, with a value of 19.03%, QS51 belongs to the top of the industry, outperforming 85.96% of the companies in the same industry.
QS51 has a better Return On Invested Capital (19.95%) than 98.25% of its industry peers.
QS51 had an Average Return On Invested Capital over the past 3 years of 19.58%. This is significantly above the industry average of 8.57%.
The 3 year average ROIC (19.58%) for QS51 is below the current ROIC(19.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.73% | ||
| ROE | 19.03% | ||
| ROIC | 19.95% |
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
1.3 Margins
The Profit Margin of QS51 (15.51%) is better than 84.21% of its industry peers.
QS51's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 25.97%, QS51 belongs to the top of the industry, outperforming 91.23% of the companies in the same industry.
QS51's Operating Margin has been stable in the last couple of years.
QS51 has a better Gross Margin (71.40%) than 82.46% of its industry peers.
QS51's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.97% | ||
| PM (TTM) | 15.51% | ||
| GM | 71.4% |
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
2. Health
2.1 Basic Checks
QS51 has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, QS51 has about the same amount of shares outstanding.
Compared to 5 years ago, QS51 has more shares outstanding
Compared to 1 year ago, QS51 has an improved debt to assets ratio.
2.2 Solvency
QS51 has an Altman-Z score of 8.58. This indicates that QS51 is financially healthy and has little risk of bankruptcy at the moment.
QS51's Altman-Z score of 8.58 is amongst the best of the industry. QS51 outperforms 92.98% of its industry peers.
The Debt to FCF ratio of QS51 is 1.49, which is an excellent value as it means it would take QS51, only 1.49 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.49, QS51 belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.
QS51 has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of QS51 (0.11) is better than 77.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | 8.58 |
ROIC/WACC3.99
WACC5%
2.3 Liquidity
A Current Ratio of 1.61 indicates that QS51 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.61, QS51 is in line with its industry, outperforming 43.86% of the companies in the same industry.
QS51 has a Quick Ratio of 1.15. This is a normal value and indicates that QS51 is financially healthy and should not expect problems in meeting its short term obligations.
QS51's Quick ratio of 1.15 is in line compared to the rest of the industry. QS51 outperforms 52.63% of its industry peers.
The current and quick ratio evaluation for QS51 is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.15 |
3. Growth
3.1 Past
The earnings per share for QS51 have decreased by -0.72% in the last year.
Measured over the past 5 years, QS51 shows a small growth in Earnings Per Share. The EPS has been growing by 5.26% on average per year.
Looking at the last year, QS51 shows a quite strong growth in Revenue. The Revenue has grown by 9.98% in the last year.
Measured over the past years, QS51 shows a quite strong growth in Revenue. The Revenue has been growing by 9.42% on average per year.
EPS 1Y (TTM)-0.72%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-26.32%
Revenue 1Y (TTM)9.98%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%8.65%
3.2 Future
Based on estimates for the next years, QS51 will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.11% on average per year.
The Revenue is expected to grow by 10.65% on average over the next years. This is quite good.
EPS Next Y31.67%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
EPS Next 5Y19.11%
Revenue Next Year7.62%
Revenue Next 2Y8.75%
Revenue Next 3Y9.04%
Revenue Next 5Y10.65%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 36.79, which means the current valuation is very expensive for QS51.
The rest of the industry has a similar Price/Earnings ratio as QS51.
QS51 is valuated rather expensively when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 27.92, QS51 can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as QS51.
QS51's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 34.09.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.79 | ||
| Fwd PE | 27.92 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QS51 is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as QS51.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.89 | ||
| EV/EBITDA | 20.09 |
4.3 Compensation for Growth
QS51's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
QS51 has an outstanding profitability rating, which may justify a higher PE ratio.
QS51's earnings are expected to grow with 19.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.16
PEG (5Y)6.99
EPS Next 2Y22.85%
EPS Next 3Y19.99%
5. Dividend
5.1 Amount
With a yearly dividend of 0.93%, QS51 is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.09, QS51 pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, QS51's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.93% |
5.2 History
The dividend of QS51 is nicely growing with an annual growth rate of 10.12%!
Dividend Growth(5Y)10.12%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
34.88% of the earnings are spent on dividend by QS51. This is a low number and sustainable payout ratio.
QS51's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.88%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
FRA:QS51 (8/8/2025, 7:00:00 PM)
107.05
-1.85 (-1.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners38.22%
Inst Owner ChangeN/A
Ins Owners32.32%
Ins Owner ChangeN/A
Market Cap17.07B
Analysts73.33
Price Target138.97 (29.82%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.93% |
Yearly Dividend0.9
Dividend Growth(5Y)10.12%
DP34.88%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.86%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.8%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.79 | ||
| Fwd PE | 27.92 | ||
| P/S | 6.42 | ||
| P/FCF | 50.89 | ||
| P/OCF | 33.23 | ||
| P/B | 7.87 | ||
| P/tB | 14.13 | ||
| EV/EBITDA | 20.09 |
EPS(TTM)2.91
EY2.72%
EPS(NY)3.83
Fwd EY3.58%
FCF(TTM)2.1
FCFY1.96%
OCF(TTM)3.22
OCFY3.01%
SpS16.69
BVpS13.6
TBVpS7.57
PEG (NY)1.16
PEG (5Y)6.99
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.73% | ||
| ROE | 19.03% | ||
| ROCE | 24.3% | ||
| ROIC | 19.95% | ||
| ROICexc | 24.14% | ||
| ROICexgc | 40.83% | ||
| OM | 25.97% | ||
| PM (TTM) | 15.51% | ||
| GM | 71.4% | ||
| FCFM | 12.61% |
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
ROICexc(3y)24.47%
ROICexc(5y)23.84%
ROICexgc(3y)42.44%
ROICexgc(5y)41.27%
ROCE(3y)23.86%
ROCE(5y)21.7%
ROICexcg growth 3Y-8.65%
ROICexcg growth 5Y-1.8%
ROICexc growth 3Y-7.31%
ROICexc growth 5Y1.25%
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.29 | ||
| Cap/Depr | 115.76% | ||
| Cap/Sales | 6.7% | ||
| Interest Coverage | 43.15 | ||
| Cash Conversion | 60.78% | ||
| Profit Quality | 81.28% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.15 | ||
| Altman-Z | 8.58 |
F-Score7
WACC5%
ROIC/WACC3.99
Cap/Depr(3y)127.11%
Cap/Depr(5y)116.21%
Cap/Sales(3y)7.81%
Cap/Sales(5y)7.04%
Profit Quality(3y)86.54%
Profit Quality(5y)138.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.72%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-26.32%
EPS Next Y31.67%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
EPS Next 5Y19.11%
Revenue 1Y (TTM)9.98%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%8.65%
Revenue Next Year7.62%
Revenue Next 2Y8.75%
Revenue Next 3Y9.04%
Revenue Next 5Y10.65%
EBIT growth 1Y3.25%
EBIT growth 3Y6.31%
EBIT growth 5Y9.56%
EBIT Next Year31.64%
EBIT Next 3Y18.52%
EBIT Next 5Y17.67%
FCF growth 1Y0.35%
FCF growth 3Y-10.44%
FCF growth 5Y6.66%
OCF growth 1Y-4.08%
OCF growth 3Y-4.8%
OCF growth 5Y5.01%